220 related articles for article (PubMed ID: 34256045)
1. Levo-tetrahydropalmatine: A new potential medication for methamphetamine addiction and neurotoxicity.
Liu L; Liu M; Zhao W; Zhao YL; Wang Y
Exp Neurol; 2021 Oct; 344():113809. PubMed ID: 34256045
[TBL] [Abstract][Full Text] [Related]
2. Roles of levo-tetrahydropalmatine in modulating methamphetamine reward behavior.
Su HL; Zhu J; Chen YJ; Zhao N; Han W; Dang YH; Xu M; Chen T
Physiol Behav; 2013 Jun; 118():195-200. PubMed ID: 23711566
[TBL] [Abstract][Full Text] [Related]
3. Levo-tetrahydropalmatine, a natural, mixed dopamine receptor antagonist, inhibits methamphetamine self-administration and methamphetamine-induced reinstatement.
Gong X; Yue K; Ma B; Xing J; Gan Y; Wang D; Jin G; Li C
Pharmacol Biochem Behav; 2016 May; 144():67-72. PubMed ID: 26806555
[TBL] [Abstract][Full Text] [Related]
4. Levo-tetrahydropalmatine attenuates the development and expression of methamphetamine-induced locomotor sensitization and the accompanying activation of ERK in the nucleus accumbens and caudate putamen in mice.
Zhao N; Chen Y; Zhu J; Wang L; Cao G; Dang Y; Yan C; Wang J; Chen T
Neuroscience; 2014 Jan; 258():101-10. PubMed ID: 24269936
[TBL] [Abstract][Full Text] [Related]
5. Levo-tetrahydropalmatine attenuates methamphetamine reward behavior and the accompanying activation of ERK phosphorylation in mice.
Su H; Sun T; Wang X; Du Y; Zhao N; Zhu J; Yan J; Chen T; Yun K
Neurosci Lett; 2020 Jan; 714():134416. PubMed ID: 31398456
[TBL] [Abstract][Full Text] [Related]
6. L-tetrahydropalmatine inhibits methamphetamine-induced locomotor activity via regulation of 5-HT neuronal activity and dopamine D3 receptor expression.
Yun J
Phytomedicine; 2014 Sep; 21(11):1287-91. PubMed ID: 25172791
[TBL] [Abstract][Full Text] [Related]
7. The inhibitory effect of levo-tetrahydropalmatine on the methamphetamine-induced spatial memory impairment in mice.
Cao G; Zhang Y; Zhu L; Zhu J; Zhao N; Dong N; Dang Y; Chen Y; Chen T
Neurosci Lett; 2018 Apr; 672():34-39. PubMed ID: 29447954
[TBL] [Abstract][Full Text] [Related]
8. Levo-tetrahydropalmatine attenuates the acquisition of fentanyl-induced conditioned place preference and the changes in ERK and CREB phosphorylation expression in mice.
Du K; Wang Z; Zhang H; Zhang Y; Su H; Wei Z; Zhang C; Yun K; Cong B
Neurosci Lett; 2021 Jun; 756():135984. PubMed ID: 34029649
[TBL] [Abstract][Full Text] [Related]
9. Tetrahydropalmatine Regulates BDNF through TrkB/CAM Interaction to Alleviate the Neurotoxicity Induced by Methamphetamine.
Liu L; Liu M; Zhao W; Zhao YL; Wang Y
ACS Chem Neurosci; 2021 Sep; 12(18):3373-3386. PubMed ID: 34448569
[TBL] [Abstract][Full Text] [Related]
10. l-Scoulerine attenuates behavioural changes induced by methamphetamine in zebrafish and mice.
Mi G; Gao Y; Yan H; Jin X; Ye E; Liu S; Gong Z; Yang H; Yang Z
Behav Brain Res; 2016 Feb; 298(Pt A):97-104. PubMed ID: 26433144
[TBL] [Abstract][Full Text] [Related]
11. Levo-tetrahydropalmatine inhibits the acquisition of ketamine-induced conditioned place preference by regulating the expression of ERK and CREB phosphorylation in rats.
Du Y; Du L; Cao J; Hölscher C; Feng Y; Su H; Wang Y; Yun KM
Behav Brain Res; 2017 Jan; 317():367-373. PubMed ID: 27713001
[TBL] [Abstract][Full Text] [Related]
12. Minocycline, an antibiotic with inhibitory effect on microglial activation, attenuates the maintenance and reinstatement of methamphetamine-seeking behavior in rat.
Attarzadeh-Yazdi G; Arezoomandan R; Haghparast A
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():142-8. PubMed ID: 24768984
[TBL] [Abstract][Full Text] [Related]
13. Corydaline and l-tetrahydropalmatine attenuate morphine-induced conditioned place preference and the changes in dopamine D
Jiang WN; Jing X; Li M; Deng H; Jiang T; Xiong KZ; Chen Y; Wang XF; Wang QJ
Eur J Pharmacol; 2020 Oct; 884():173397. PubMed ID: 32717192
[TBL] [Abstract][Full Text] [Related]
14. Neurotoxicity of methamphetamine: Main effects and mechanisms.
Jayanthi S; Daiwile AP; Cadet JL
Exp Neurol; 2021 Oct; 344():113795. PubMed ID: 34186102
[TBL] [Abstract][Full Text] [Related]
15. Patterns of methamphetamine abuse and their consequences.
Cho AK; Melega WP
J Addict Dis; 2002; 21(1):21-34. PubMed ID: 11831497
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of levo-tetrahydropalmatine attenuates reinstatement of extinguished cocaine seeking by cocaine, stress or drug-associated cues in rats.
Figueroa-Guzman Y; Mueller C; Vranjkovic O; Wisniewski S; Yang Z; Li SJ; Bohr C; Graf EN; Baker DA; Mantsch JR
Drug Alcohol Depend; 2011 Jul; 116(1-3):72-9. PubMed ID: 21196089
[TBL] [Abstract][Full Text] [Related]
17. The Role of α-Synuclein in Methamphetamine-Induced Neurotoxicity.
Wu M; Su H; Zhao M
Neurotox Res; 2021 Jun; 39(3):1007-1021. PubMed ID: 33555547
[TBL] [Abstract][Full Text] [Related]
18. CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice.
Kaushal N; Seminerio MJ; Shaikh J; Medina MA; Mesangeau C; Wilson LL; McCurdy CR; Matsumoto RR
Neuropharmacology; 2011; 61(5-6):992-1000. PubMed ID: 21762711
[TBL] [Abstract][Full Text] [Related]
19. The dopamine receptor antagonist levo-tetrahydropalmatine attenuates heroin self-administration and heroin-induced reinstatement in rats.
Yue K; Ma B; Ru Q; Chen L; Gan Y; Wang D; Jin G; Li C
Pharmacol Biochem Behav; 2012 Jul; 102(1):1-5. PubMed ID: 22741173
[TBL] [Abstract][Full Text] [Related]
20. Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine.
Itzhak Y; Martin JL; Ali SF
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1177-83. PubMed ID: 12452543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
